AUA Congress 2023
AUA 2023 Prostate Cancer
- AUA 2023: Phase 3 Randomized Study of Enzalutamide or Placebo Plus Leuprolide Acetate and Enzalutamide Monotherapy in High-Risk Biochemically Recurrent Prostate Cancer: EMBARK
- AUA 2023: Role and Extent of Pelvic Lymph Node Dissection in PSMA Era
- AUA 2023: Single Port Robotic Assisted Radical Prostatectomy, Technical Point of View
- AUA 2023: Infectious and Non-Infectious Complications Following Prostate Biopsy: A Randomized Clinical Trial
- AUA 2023: Oligometastatic Disease—Who/Why for Directed Therapy
AUA 2023 Bladder Cancer
- AUA 2023: Very High Risk NMIBC: Radical Cystectomy or Intravesical Therapy
- AUA 2023: Bladder Preservation in Muscle Invasive Bladder Cancer: Myth or Reality
- AUA 2023: Outcomes and Genomic Characteristics of Newly Diagnosed High Grade Ta Papillary Urothelial Carcinoma Treated with Intravesical Chemotherapy vs BCG: A Comparative Study During the BCG Shortage
- AUA 2023: Chemotherapy Vs Immunotherapy as Neoadjuvant Therapies in Cisplatin-Eligible Patients Undergoing Radical Cystectomy for Muscle Invasive Bladder Cancer
- AUA 2023: Evaluation of Gender Specific Differences in Health-Related Quality of Life for Bladder Cancer Patients After Radical Cystectomy - Results From a Large Prospective Propensity Score-Matched Cohort
AUA 2023 Kidney Cancer
- AUA 2023: Development of an Individual Postoperative Prediction Model for Kidney Cancer Recurrence Using Machine Learning (UroCCR Study 120)
- AUA 2023: The Metastatic Potential of Renal Masses is Underappreciated: A Size Analysis Stratified By Histology
- AUA 2023: Cost-Effectiveness Analysis of Universal CT Staging Versus Selective CT Staging Strategies for Patients with cT1a Renal Masses
- AUA 2023: True Local Recurrence Following Partial Nephrectomy
- AUA 2023: Evaluation of American Urological Association Renal Cell Carcinoma Risk Groups for Chromophobe Renal Cell Carcinoma
AUA 2023 Testicular and Penile Cancer
AUA 2023 Press Release
- Clinical Study Results of the BlueWind System for Patients with Overactive Bladder Featured at the 2023 AUA Annual Meeting
- Urologists Explore the Impacts of the Dobbs Decision on Men Seeking Vasectomies
- Urologists Explore AI for Prostate Cancer Detection and the Effects of Prostate Cancer on Female Partners
- Urologists Explore Treatments for Recurrent UTIs, the Financial Burden of UTIs and UTI Information on Social Media
- Urologists Explore the Validity of Urologic Information on Social Media
AUA 2023 Stone Disease
- AUA 2023: Machine Learning Prediction of Symptomatic Kidney Stone Recurrence Using 24-Hour Urine Data and Electronic Health Record Derived Features
- AUA 2023: A Novel Machine-Learning Algorithm to Predict Stone Recurrence with 24-hour Urine Data
- AUA 2023: Ureteral Stent Biomaterial Encrustation after Endoscopic Surgery: A Prospective Randomized Study
- AUA 2023: Efficacy and Safety of a Magnetic Hydrogel for Stone Fragment Removal: An In Vitro and In Vivo Study
- AUA 2023: John K. Lattimer Lecture Innovation in Urology: From a Seminal “Why” to a Functional “How”
AUA 2023 Upper Tract Urothelial Carcinoma
- AUA 2023: Urinary Comprehensive Genomic Profiling Aids in Detection and Risk Prognosis of Upper Tract Urothelial Carcinoma: A Case-Controlled Cohort Study
- AUA 2023: Gender Disparities in Upper Tract Urothelial Carcinoma
- AUA 2023: Efficacy and Safety of Mitomycin Gel (UGN-101) as an Adjuvant Therapy After Complete Endoscopic Management of Upper Tract Urothelial Carcinoma
- AUA 2023: Diagnostic Accuracy of Oncuria-Detect in the Detection of Upper Tract Urothelial Tumors
- AUA 2023: Automated Segmentation of Upper Urinary Tract Tumors During Ureteroscopy Using Computer Vision Techniques